US Bancorp’s HANSEN MEDICAL, INC. COM NEW HNSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-12,150
Closed -$49K 3752
2016
Q2
$49K Hold
12,150
﹤0.01% 2417
2016
Q1
$32K Hold
12,150
﹤0.01% 2588
2015
Q4
$28K Buy
12,150
+1,350
+13% +$4.41K ﹤0.01% 2699
2015
Q3
$41K Buy
10,800
+450
+4% +$2.94K ﹤0.01% 2562
2015
Q2
$95K Buy
10,350
+5,100
+97% +$46.5K ﹤0.01% 2179
2015
Q1
$46K Buy
5,250
+5,000
+2,000% +$40.6K ﹤0.01% 2591
2014
Q4
$1K Buy
+250
New +$2.07K ﹤0.01% 3505
2014
Q1
Sell
-220
Closed -$4K 3616
2013
Q4
$4K Sell
220
-550
-71% -$10.2K ﹤0.01% 3202
2013
Q3
$14K Sell
770
-230
-23% -$3.62K ﹤0.01% 2804
2013
Q2
$14K Buy
+1,000
New +$17.7K ﹤0.01% 2786

US Bancorp's HNSN Position: Q3 2016 in Review

US Bancorp sold out of HANSEN MEDICAL, INC. COM NEW (HNSN) in Q3 2016, closing a stake of 12,150 shares — an estimated $49K sold.

US Bancorp first reported a position in HNSN in Q2 2013 and held it in 10 quarters. The position peaked at $95K in Q2 2015. 0 funds tracked by Wall St. Rank hold HNSN as of Q3 2016.

  • US Bancorp reported no remaining HANSEN MEDICAL, INC. COM NEW position as of Q3 2016 after selling out during the quarter.
  • US Bancorp sold 12,150 HANSEN MEDICAL, INC. COM NEW shares in Q3 2016, an estimated $49K.
  • US Bancorp first reported a position in HANSEN MEDICAL, INC. COM NEW in Q2 2013 and held it in 10 quarters.
  • US Bancorp's HANSEN MEDICAL, INC. COM NEW position peaked at $95K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held HANSEN MEDICAL, INC. COM NEW as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.